PHF5A and lung carcinoma: In addition, when using PHF5A small molecular inhibitor pladienolide to treat H1299 and A549 cell lines, we found that pladienolide significantly inhibited LUAD cell proliferation in a dose–dependent manner and induced AS events similar to those obtained in PHF5A knockdown, indicating that PHF5A might be a potential drug target in lung cancer treatment.